Press release
Emerging Opportunities in Complex Regional Pain Syndrome Market with Current Trends Analysis
Complex Regional Pain syndrome (CRPS), which is also known as “reflex sympathetic dystrophy syndrome” is an uncommon kind of chronic pain condition characterized by severe pain and inflammation. CRPS develops after an injury, stroke or surgery and the pain is associated with the severity of the initial injury. CRPS is most common in people of age group 20-35 and more common in women than men. CRPS is also observed in children due to their injuries. Excluding the severe pain the other symptoms for CRPS include swelling and stiffness in joints, changes in the growth of nails, burning sensation and skin changes in appearance and temperature. Emotional stress can also trigger CRPS and heighten the pain sensations in an individual.The complex regional pain syndrome is basically of two types according to the National Health Service (NHS) U.K, CRPS 1 also called reflex sympathetic dystrophy, it is an unknown condition resulting from the injury of limb which can also be related to genetics hence, likely to be a hereditary disorder. CRPS 2 is an extreme severe painful response to peripheral nerve injury but the pain does not migrate from the original site of injury unlike CRPS 1. Diagnosis of CRPS depends upon the individual’s medical history and symptoms as there is no single diagnostic test for it. The incidence rates reveal that female are three times more affected than male and occurs in the age over 60. According to a study conducted in U.K, 1 in 3,800 people develop CRPS each year.
Request Free Report Sample@ http://www.futuremarketinsights.com/toc/rep-gb-1708
The global market for CRPS is segmented on basis of treatment and distribution channel:
Segmentation by treatment therapies of complex regional pain syndrome
Physical Therapy
Drugs
Analgesics
Antidepressants
Corticosteroids
Others
Surgical sympathectomy
Intrathecal drug pumps
Spinal cord stimulation
Segmentation by distribution channel of complex regional pain syndrome
Pharmacies
Hospitals
Clinics
Research Organizations
As CRPS can begin at any age including children, 90% of CRPS occurs if enough care is not taken by an individual after any serious injury such as fractures, soft tissue injury, limb immobilization, sprains and surgical procedures. National Institutes of Health (NIH) is supporting research for CRPS on the brain and CNS by focusing on studying new approaches in treating CRPS.
On the basis of region prevalence, CRPS is segmented into five key regions: North America, Latin America, Europe, Asia Pacific, and Middle East & Africa.
As it is one of the rare condition there is limited data available for regional market share for CRPS but there are 50% chances of multiple sclerosis (MS) patients to develop CRPS and currently North America is one of the leading region in terms of market share followed by Europe and Asia pacific.
Some of the key market players of the complex regional pain syndrome market include Mallinckrodt Pharmaceutical, GlaxoSmithKline plc., Mylan N.V., Teva Pharmaceutical Industries Ltd., AbbVie, ACTAVIS, Zydus Pharmaceuticals, Inc., Sandoz, and Janssen Global Services, LLC..
About Us – Future Market Insights is the premier provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in London, the global financial capital, and has delivery centers in the U.S. and India.
Contact Us:
Future Market Insights
616 Corporate Way,
Suite 2-9018,
Valley Cottage,
New York 10989,
United States
Tel: +1-347-918-3531
Fax: +1-845-579-5705
Email: sales@futuremarketinsights.com
Website: www.futuremarketinsights.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Emerging Opportunities in Complex Regional Pain Syndrome Market with Current Trends Analysis here
News-ID: 384917 • Views: …
More Releases from Future Market Insights

External Anti-infective Preparations Market USD 6,728.7 Million through 2035, Dr …
The global external anti-infective preparations market is on track for sustained growth, with revenues projected to rise from USD 5,412.8 million in 2025 to approximately USD 6,728.7 million by 2035, representing an absolute increase of USD 1,315.9 million and a compound annual growth rate (CAGR) of 2.2%. This expansion is fueled by the increasing prevalence of external infections and the growing demand for localized antimicrobial treatment solutions across hospitals, clinics,…

External Anti-infective Preparations Market USD 6,728.7 Million through 2035, Dr …
The global external anti-infective preparations market is on track for sustained growth, with revenues projected to rise from USD 5,412.8 million in 2025 to approximately USD 6,728.7 million by 2035, representing an absolute increase of USD 1,315.9 million and a compound annual growth rate (CAGR) of 2.2%. This expansion is fueled by the increasing prevalence of external infections and the growing demand for localized antimicrobial treatment solutions across hospitals, clinics,…

External Anti-infective Preparations Market USD 6,728.7 Million through 2035, Dr …
The global external anti-infective preparations market is on track for sustained growth, with revenues projected to rise from USD 5,412.8 million in 2025 to approximately USD 6,728.7 million by 2035, representing an absolute increase of USD 1,315.9 million and a compound annual growth rate (CAGR) of 2.2%. This expansion is fueled by the increasing prevalence of external infections and the growing demand for localized antimicrobial treatment solutions across hospitals, clinics,…

External Anti-infective Preparations Market USD 6,728.7 Million through 2035, Dr …
The global external anti-infective preparations market is on track for sustained growth, with revenues projected to rise from USD 5,412.8 million in 2025 to approximately USD 6,728.7 million by 2035, representing an absolute increase of USD 1,315.9 million and a compound annual growth rate (CAGR) of 2.2%. This expansion is fueled by the increasing prevalence of external infections and the growing demand for localized antimicrobial treatment solutions across hospitals, clinics,…
More Releases for CRPS
Complex Regional Pain Syndrome (CRPS) Market New Product Development & Latest Tr …
Introduction
Complex Regional Pain Syndrome (CRPS) is a chronic, rare neurological disorder that typically develops after an injury, fracture, or surgery. It is characterized by disproportionate pain, changes in skin color and temperature, swelling, and limited mobility. Although rare, CRPS has a profound impact on patients' quality of life and poses challenges for healthcare providers due to its complex diagnosis and management.
Growing awareness of chronic pain syndromes, increased demand for effective…
Inside the Cycle of CRPS: Stella Artuso's Story of Resilience
Stella Artuso's condition seemed to be incurable until her parents found the Arkansas-based Spero Clinic. This is a one-of-a-kind facility specializing in treating conditions such as Complex Regional Pain Syndrome.
Image: https://www.globalnewslines.com/uploads/2025/04/b46865964236fed3bbd45c5bc89f50e1.jpg
"I always felt like I was present in moments, but I was separated by a barrier of pain. I couldn't smile without faking." - Stella Arturo.
Imagine being 12 years old, enjoying life, sports, running, and having a great time. Then,…
A New Chapter: The Spero Clinic Helps CRPS Patient Lou Reclaim Her Life
CRPS is causing constant, debilitating pain for people around the world. Here's what The Spero Clinic is doing to save lives from this dreadful disease.
Image: https://www.globalnewslines.com/uploads/2025/02/a3269782b20b4832d25263680ae9bac8.jpg
"I had absolute plans to kill myself because I just thought this is not a life that I want."
Statements such as these sound alarming, but the truth is that many patients suffering from Complex Regional Pain Syndrome (CRPS) end up feeling this way. Why?
Because CRPS,…
Paula's Journey: CRPS Survivor Finds Hope and Healing at the Spero Clinic
Paula, a survivor of Complex Regional Pain Syndrome (CRPS), shares her transformative journey toward healing at The Spero Clinic. CRPS is a chronic pain condition affecting millions, often triggered by an injury or medical event, causing severe pain, muscle spasms, and mobility issues.
Image: https://www.globalnewslines.com/uploads/2025/02/2ce8be74be632434741ecf707cfafe58.jpg
CRPS, or Complex Regional Pain Syndrome, is a chronic pain condition that affects between 5 and 8 million people around the world. CRPS [https://www.thesperoclinic.com/conditions/complex-regional-pain-syndrome/] is often triggered…
Award-Winning Director Charles Mattocks Teams Up with Scrambler Therapy for Grou …
Image: https://www.abnewswire.com/upload/2025/01/eb1c2b4539342e8dbad4e6c84149a2cf.jpg
Acclaimed director Charles Mattocks, known for his impactful films and TV programs focused on health-related content, has partnered with Scrambler Therapy, a pioneering company in the field of Technology for Effective Pain Relief, to feature their innovative treatment in his upcoming documentary on Complex Regional Pain Syndrome (CRPS). This documentary is the second installment of Mattocks' awardwinning series exploring rare and debilitating diseases, with a special focus on CRPS.
Mattocks'…
Complex Regional Pain Syndrome (CRPS) Market to expand at a 2.2% value CAGR by 2 …
The global complex regional pain syndrome (CRPS) market is expected to be worth US$ 101.9 million in 2022, rising to US$ 126.7 million by 2032. During the forecast period of 2022 to 2032, the market is expected to grow at a 2.2% CAGR.
Request Sample@ https://www.futuremarketinsights.com/reports/sample/rep-gb-1708
Complex Regional Pain Syndrome (CRPS) is a chronic condition that causes severe pain in legs, arms, feet, and hands or may involve the entire body. CRPS…